Ovation Diagnostics – Ovarian Cancer Detection

Ovation Diagnostics is dedicated to developing advanced and accessible ovarian cancer diagnostic technologies to address a global unmet need.

The Problem: Early Detection of Ovarian Cancer

    • Ovarian cancer is the fifth leading cause of cancer induced death among women in the US
      • Women currently affected with ovarian cancer
        • In the US = 22,000
        • In the world = 180,000
    • Prognosis is poor; 5 year survival is no better than 37%
    • Current tests fail to provide reliable screening at stage I of ovarian cancer
    • About 60% of women are being diagnosed after the disease has spread beyond the ovary

The Solution: Ovation Diagnostics

    • Early diagnosis is critical to reduce the risk of death from ovarian cancer
    • Screening of ovarian cancer is necessary to identify early stages of ovarian cancer
    • Using a urine dipstick instead of diagnosing through blood samples will make screening easier
    • Levels of a protein marker called Bcl-2 are elevated in the urine of patients with ovarian cancer and are of diagnostic and/or prognostic clinical importance
      • Prognosis is greater than 90% if identified in Stage 1
    • Early diagnosis is critical to reduce the risk of death from ovarian
image logo for footer

Contact Details

138 NW 16th Street
Boca Raton, FL 33432

Phone: 561-705-0452
Fax: 561-807-7302
Email: info@impactmedicalstrategies.com